FDA Drug recall D-0185-2016
BIEST CP 80/20 (Estradiol (E2) Trit (Yellow)/Estriol USP Micronized (E3)) 1.25 MG capsules, Rx only, The Compounder, 340 Marshall Avenue Un…
- FDA Drug
- Class II
- terminated
- Published 2015-11-18
On 2015-11-18 the FDA classified a Class II recall of BIEST CP 80/20 (Estradiol (E2) Trit (Yellow)/Estriol USP Micronized (E3)) 1.25 MG capsules, Rx only, The Compounder, 340 Marshall Avenue Un… by The Compounder, citing recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0185-2016 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2015-03-10 |
| Published | 2015-11-18 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | The Compounder |
| Distribution | US |
Product
BIEST CP 80/20 (Estradiol (E2) Trit (Yellow)/Estriol USP Micronized (E3)) 1.25 MG capsules, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.
Reason
Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.
Identifiers
| code_info | Lot # 02182015:78@22, Exp 2/18/2016; Lot # 02182015:98@23, Exp 2/18/2016 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0185-2016%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.